Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3840

Full Length Research Paper

Anti-proliferative and cytotoxic effects of methanol extract of the leaves of Momordica charantia L. (Cucurbitaceae) on vascular smooth muscle cells (VSMC) and HT-29 cell lines

Ofuegbe S. O.
  • Ofuegbe S. O.
  • Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Nigeria.
  • Search for this author on:
  • Google Scholar
Oyagbemi A. A.
  • Oyagbemi A. A.
  • Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Oyo, Nigeria.
  • Search for this author on:
  • Google Scholar
Omobowale T. O.
  • Omobowale T. O.
  • Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Oyo, Nigeria.
  • Search for this author on:
  • Google Scholar
Fagbohun O. S.
  • Fagbohun O. S.
  • Department of Veterinary Microbiology, Faculty of Veterinary Medicine, University of Ibadan, Oyo, Nigeria.
  • Search for this author on:
  • Google Scholar
Yakubu M. A.
  • Yakubu M. A.
  • Department of Environmental and Interdisciplinary Sciences, College of Science, Engineering and Technology, Texas Southern University, Houston, TX, USA.
  • Search for this author on:
  • Google Scholar
Adedapo A. A.
  • Adedapo A. A.
  • Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Nigeria.
  • Search for this author on:
  • Google Scholar


  •  Received: 23 September 2017
  •  Accepted: 09 October 2017
  •  Published: 10 November 2017

References

Abdel-Wahab O, Levine RL (2010). Recent advances in the treatment of acute myeloid leukemia. F1000 Med. Rep. 2(1):55.
Crossref
 

Abhishek T, Sudhir K, Mangala D (2004). Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycaemic potentiation of oral hypoglycaemic drugs in diabetes mellitus (NIDDM). Indian J. Pharm. 48:241-244.

  
 

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004). Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. A. 24(5):2783-2840.

  
 

Aggarwal BB, Kumar A, Bharti AC (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. A 23(1):363-398.

  
 

Akhisa T, Higo N, Tokuda H, Ukiya M, Akazawa H, Tochigi H, Kimura Y, Suzuki T, Nishino H (2007). Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J. Nat. Prod. 70(8):1233-1239.
Crossref

  
 

Anila L, Vijayalakshmi NR (2000). Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother. Res. 14:592-595.
Crossref

  
 

Basch E, Gabardi S, Ulbricht C (2003). Bitter melon (Momordica charantia): A review of efficacy and safety. Am. J. Health Syst. Pharm. 65:356-359.

  
 

Betty RK, Jonathan AC (2003). Essential medical statistics. Kirkwood and Jonathan AC Sterne: Blackwell Science Ltd. pp. 414-425.

  
 

Chang CI, Chen CR, Liao YW, Cheng HL, Chen YC, Chou CH (2008). Cucurbitane-type triterpenoids from the stems of Momordica charantia. Nature 71:1327-1330.

  
 

Chia-Jung L, Shih-Fang T, Chun-Hao T, Hsin-Yi T, Jong-Ho C, Hsue-Yin H (2012). Momordica charantia extract induces apoptosis in human cancer cells through caspase- and mitochondria-dependent pathways. Evid. Based Complement Altern. Med. 2012:261971.

  
 

Chopra A, Doiphode VV (2002). Ayurvedic medicine: core concept, therapeutic principles, and current relevance. Med. Clin. 86(1):75-89.
Crossref

  
 

Cunnick JE, Sakamoto K, Chapes SK, Fortner GW, Takemoto DJ (1990). Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cell. Immunol. 126:278-289.
Crossref

  
 

El-Said SM, Al-Barak AS (2011). Extraction of insulin like compounds from bitter melon plants. Am. J. Drug Dis. Dev. 1(1):1-7.
Crossref

  
 

Global Burden of Disease (GBD) (2015). Mortality and Causes of Death, Collaborators. (8 October 2016). Global, regional and national life expectancy, all-cause mortality and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study. Lancet 388(10053):1459-1544.

  
 

Jilka CB, Strifler WG, Fortner FE, Takemoto JD (1983). In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res. 43:5151-5155.

  
 

Jjiratchariyakul WC, Wiwat M, Vongsakul A, Somanabandhu WL, fujii NS, Ebizuka Y (2001). HIV inhibitor from Thai bitter gourd. Planta Med. 67: 350-353.
Crossref

  
 

Johnson IT (2004). New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat. Res. 551(1-2):9-28.
Crossref

  
 

Jutamas S, Sumonthip K, Nuttawan Y, Tanawan K, Weena J (2015). Antibacterial and antiproliferative activities of Plumericin, an iridoid isolated from Momordica charantia vine. Evid. Based Complement. Altern. Med. 2015:10.

  
 

Kähkönen MP, Hopia AI, Vuorela HJ (1999). Antioxidant activity of plant extracts containing phenolic compounds. J. Agric. Food Chem. 47(10):3954-3962.
Crossref

  
 

Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61(3):215-225.
Crossref

  
 

Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT (2003). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256-2264.
Crossref

  
 

Lee-Huang S, Huang PL, Chen HC (1995). Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene 161(2):151-156.
Crossref

  
 

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S (2009). Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): A mini review. Br. J. Nutr. 102(12):1703-1708.
Crossref

  
 

Lewandowicz GM, Harding B, Harkness W, Hayward R, Thomas DG, Darling JL (2000). Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine. Cancer 36:1955-1964.
Crossref

  
 

Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004). Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 79(5):727-747.

  
 

Nagasawa H, Watanabe K, Inatomi H (2002). Effects of bitter melon (Momordica charantia) or ginger rhizome (Zingiber offifinale Rosc.) on spontaneous mammary tumorigenesis in SHN mice. J. Clin. Med. 30(2):195-205.

  
 

Potawale SS, Bhandari A, Jadhav H, Dhalawat Y, Vetal P, Deshpande RD (2008). A Review on Phytochemical and Pharmacological Properties of Momordica Charantia Linn. Pharmocoglycine 2:319-335.

  
 

Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresma M, Shah A, Walters S, Woods L, Forman D, Coleman MP (2010). Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br. J. Cancer 103(4):446-453.
Crossref

  
 

Riboli E, Norat T (2003). Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 78(3):559S-569S.

  
 

Soundararajan R, Prabha P, Rai U, and Dixit A (2012). Antileukemic potential of Momordica charantia seed extracts on human myeloid leukemic HL60 cells. Evidence-Based Complement. Altern. Med. 2012:10.

  
 

West ME, Sidrak GH, Street SP (1971). The anti-growth properties of extracts from Momordica charantia L. West Indian Med. J. 20(1):25-34.

  
 

Yedjou CG, Moore P, Tchounwou (2006). Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment. Int. J. Environ. Res. Pub. Health 3(2):136-140.
Crossref

  
 

Yuan YR, He YN, Xiong JP, Xia ZX (1999). Three-dimensional structure of beta-momorcharin at 2.55 a resolution. Acta Crystallogr. D Biol. Crystallogr. 55(Pt 6):1144-1151.
Crossref

  
 

Zhu ZJ, Zhong ZC, Luo ZY, Xiao ZY (1990). Studies on the active constituents of Momordica charantia L. Yaoxue Xuebao 25:898-903.

  

 

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 11 No. 42
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES